| P2093 | author name string | James M Brophy | |
| | Paul Brassard | |
| | Zhi Song | |
| P2860 | cites work | Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses | Q27860840 |
| | Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? | Q29619328 |
| | Effect of azithromycin on murine arteriosclerosis exacerbated by Chlamydia pneumoniae | Q31713580 |
| | Effect of clarithromycin treatment on Chlamydia pneumoniae in vascular tissue of patients with coronary artery disease: a randomized, double-blind, placebo-controlled trial | Q33752851 |
| | Antibiotics effects in a rabbit model of Chlamydia pneumoniae-induced atherosclerosis | Q33935083 |
| | Randomised placebo controlled multicentre trial to assess short term clarithromycin for patients with stable coronary heart disease: CLARICOR trial | Q34248742 |
| | Effects of antibiotic therapy on outcomes of patients with coronary artery disease: a meta-analysis of randomized controlled trials | Q34422834 |
| | Development and evaluation of real-time PCR-based fluorescence assays for detection of Chlamydia pneumoniae | Q34946766 |
| | Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease | Q35013298 |
| | Chlamydia pneumoniae and coronary artery disease: the antibiotic trials | Q35083268 |
| | Involvement of Chlamydia pneumoniae in atherosclerosis: more evidence for lack of evidence | Q36000970 |
| | Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis | Q37346172 |
| | Antibiotic treatment of Chlamydia pneumoniae after acute coronary syndrome | Q37865020 |
| | Azithromycin for the secondary prevention of coronary events | Q37865023 |
| | Antibiotics in the prevention of heart attacks | Q37865606 |
| | Treatment with clarithromycin prior to coronary artery bypass graft surgery does not prevent subsequent cardiac events | Q37865651 |
| | Azithromycin for the secondary prevention of coronary heart disease events: the WIZARD study: a randomized controlled trial | Q37868604 |
| | Effect of short-term treatment with azithromycin on recurrent ischaemic events in patients with acute coronary syndrome in the Azithromycin in Acute Coronary Syndrome (AZACS) trial: a randomised controlled trial | Q37869839 |
| | Antibiotic therapy after acute myocardial infarction: a prospective randomized study | Q37869909 |
| | Effect of treatment for Chlamydia pneumoniae and Helicobacter pylori on markers of inflammation and cardiac events in patients with acute coronary syndromes: South Thames Trial of Antibiotics in Myocardial Infarction and Unstable Angina (STAMINA). | Q37871321 |
| | Treatment of Chlamydia pneumoniae infection with roxithromycin and effect on neointima proliferation after coronary stent placement (ISAR-3): a randomised, double-blind, placebo-controlled trial | Q37873906 |
| | Randomized secondary prevention trial of azithromycin in patients with coronary artery disease: primary clinical results of the ACADEMIC study | Q37875542 |
| | Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma | Q37876372 |
| | Interaction of Chlamydia pneumoniae infection with other risk factors of atherosclerosis | Q37877539 |
| | Treatment with the antibiotic roxithromycin in patients with acute non-Q-wave coronary syndromes. The final report of the ROXIS Study | Q37878753 |
| | Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model | Q37881464 |
| | Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction | Q37882420 |
| | Expression of adhesion molecules on endothelial cells stimulated by Chlamydia pneumoniae | Q37884222 |
| | Reliability of nested PCR for the detection of Chlamydia pneumoniae in carotid artery atherosclerosis | Q43422110 |
| | Antibiotic treatment of atherosclerotic cardiovascular disease | Q43422530 |
| | Effect of 3 months of antimicrobial treatment with clarithromycin in acute non-q-wave coronary syndrome | Q43943292 |
| | Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee | Q45002081 |
| | Seasonal variations of plasma fibrinogen and factor VII activity in the elderly: winter infections and death from cardiovascular disease | Q58475992 |
| P433 | issue | 5 | |
| P921 | main subject | antibiotic | Q12187 |
| | cardiovascular disease | Q389735 |
| | meta-analysis | Q815382 |
| P304 | page(s) | 391-395 | |
| P577 | publication date | 2008-05-01 | |
| P1433 | published in | The Canadian Journal of Cardiology | Q3502278 |
| P1476 | title | A meta-analysis of antibiotic use for the secondary prevention of cardiovascular diseases | |
| P478 | volume | 24 | |